Kenya has been chosen as the first Country in Africa for study on male contraception.
Men who will qualify for the study are required to apply a gel on their shoulders that is supposed to lower the sperm count to a point where they cannot impregnate a woman.
The gel being tested is composed of the hormone nestorone, a progestin hormone commonly used for female contraception and testosterone.
The combination gel, referred to as the NES/T within the technical group, is a novel, reversible contraceptive for men designed to be absorbed through the skin on the upper arms and shoulders.
Kenyan men will join others around the world in using the daily gel for up to 52 weeks to drop the sperm count to zero. Kenya is the first African country to be chosen for a study.